1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Time To Move On

Discussion in 'Ista Pharma' started by Anonymous, Jun 26, 2012 at 8:20 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I guess those of us that are left should start posting to the B&L board now. It was a good ride. I enjoyed it. I'll miss seeing many of you at the corporate meeting. Good luck.
     
  2. Anonymous

    Anonymous Guest

    They are not telling us anything as far as the truth. I want to know how many of us will actually keep our jobs